Critical equipment en route to Australia ahead of mRNA vaccine trials
A $1 million NanoAssemblr machine, a critical part of mRNA vaccine production, has been shipped from Canada ahead of Phase 1 clinical trials for the Monash Institute of Pharmaceutical Sciences (MIPS) mRNA COVID-19 vaccine.
Details